By Ms. Friedman, a petition (accompanied by bill, Senate, No. 979) of Cindy F. Friedman, Kelly W. Pease, Jason M. Lewis, Joanne M. Comerford and other members of the General Court for legislation to provide easier and greater access to record sealing. The Judiciary.
By Ms. Friedman, a petition (accompanied by bill, Senate, No. 981) of Cindy F. Friedman for legislation relative to guilty but with a mental illness. The Judiciary.
By Mr. Lewis, a petition (accompanied by bill, Senate, No. 301) of Jason M. Lewis, Susan L. Moran, Robyn K. Kennedy, Liz Miranda and other members of the General Court for legislation to provide affordable and accessible high quality early education and care to promote child development and well-being and support the economy in the Commonwealth. Education.
Senate, January 29, 2024 --The committee on Consumer Protection and Professional Licensure, to whom was referred the petitions (accompanied by bill, Senate, No. 175) of Cindy F. Friedman, Joanne M. Comerford, Carmine Lawrence Gentile, Lydia Edwards and other members of the General Court for legislation relative to the disclosure of toxic chemicals in children’s products; and (accompanied by bill, House, No. 318) of James K. Hawkins and others for legislation to direct the Department of Environmental Protection to publish a toxic chemicals of concern consumer products list, report the accompanying bill (Senate, No. 2564).
By Ms. Friedman, a petition (accompanied by bill, Senate, No. 175) of Cindy F. Friedman, Joanne M. Comerford, Carmine Lawrence Gentile, Lydia Edwards and other members of the General Court for legislation relative to the disclosure of toxic chemicals in children’s products. Consumer Protection and Professional Licensure.
By Ms. Friedman, a petition (accompanied by bill, Senate, No. 1184) of Cindy F. Friedman, Kenneth I. Gordon, Jason M. Lewis, Michael J. Barrett and others for legislation relative to an employee protection act. Labor and Workforce Development.
By Mr. Cronin, a petition (accompanied by bill, Senate, No. 152) of John J. Cronin, Jack Patrick Lewis, Kimberly N. Ferguson, Carmine Lawrence Gentile and other members of the General Court for legislation to expand wheelchair warranty protections for consumers with disabilities. Consumer Protection and Professional Licensure.
Senate, January 2, 2024 -- The committee on Senate Ways and Means, to whom was referred the Senate Bill expanding wheelchair warranty protections for consumers with disabilities (Senate, No. 152),- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2541).
Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).
